Recruiting Clinical Trials

Displaying 231 - 240 of 242 result(s)
Study Title Condition Phase Location
A Multicenter, Prospective, Randomized, Open-label, Blinded-endpoint, Phase 4 Study to Evaluate the Efficacy and Safety of Sacubitril/Valsartan Compared With Enalapril on Morbidity, Mortality, and NT-proBNP Change in Patients With Chronic Chagas' Car ... Chagas Disease, Heart Failure Phase 4
  • Country: 
    Argentina
  • Country: 
    Brazil
  • Country: 
    Colombia
  • Country: 
Controlled Trial on the Short-term Effects of Sacubitril/Valsartan Therapy on Cardiac Oxygen Consumption and Efficiency of Cardiac Work in Patients With NYHA II-III Heart Failure and Reduced Systolic Function Using 11C-acetate Positron Emission Tomog ... Heart Failure Phase 4
  • Country: 
    Finland
A Multicenter, Interventional, Open-label and Single-arm Study to Investigate the Effect of ARNI on Ventricular Arrhythmia in HFrEF Patients With ICD or CRT-D Heart Failure Phase 4
  • Country: 
    China
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase III Multicenter Study of Intravenous Secukinumab to Compare Efficacy at 16 Weeks With Placebo and to Assess Safety and Tolerability up to 52 Weeks in Subjects With Active Psoriatic ... Psoriatic Arthritis Phase 3
  • Country: 
    Brazil
A TWINSS Extension Trial to Evaluate the Safety and Tolerability of CFZ533 (Iscalimab) at Two Dose Levels Administered Subcutaneously in Patients With Sjögren's Syndrome Sjögren's Syndrome Phase 2
  • Country: 
    Austria
  • Country: 
    France
  • Country: 
    Germany
  • Country: 
A Two-part Exploratory Study Combining a Pilot Study in Healthy Subjects and Chronic Spontaneous Urticaria Patients (Part 1) and a Randomized, Subject, Investigator and Sponsor-blinded, Placebo Controlled, Study (Part 2) to Assess the MechAniSm of ac ... Chronic Spontaneous Urticaria, Cholinergic Urticaria, Cold Urticaria Phase 1
  • Country: 
    Germany
EXPLORE: A Phase II, Outcomes Assessor-masked, Multicentre, Randomised Study to Evaluate the Safety and Efficacy of Two Doses of GT005 Administered as a Single Subretinal Injection in Subjects With Geographic Atrophy Secondary to Age-related Macular ... Dry Age-related Macular Degeneration Phase 2
  • Country: 
    United States
  • Country: 
    Australia
  • Country: 
    France
  • Country: 
A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of VAY736 in Autoimmune Hepatitis Autoimmune Hepatitis Phase 2, Phase 3
  • Country: 
    United States
  • Country: 
    Argentina
  • Country: 
    Belgium
  • Country: 
A Prospective Phase II, Open-Label, Single-arm, Multicenter, Study to Assess Efficacy and Safety of SEG101 (Crizanlizumab), in Sickle Cell Disease Patients With Priapism (SPARTAN) Priapism Phase 2
  • Country: 
    United States
A Multicenter Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan in Adult Participants With Primary IgA Nephropathy Who Have Completed Study CLNP023X2203 or CLNP023A2301 Primary IgA Nephropathy Phase 3
  • Country: 
    Belgium
  • Country: 
    Germany